our company

InGel Therapeutics is a platform technology company developing stem cell therapeutics and biodegradable polymers to enhance and create novel therapies for eye diseases.

InGel was founded in 2021, and is led by a team of committed scientists, engineers, and entrepreneurs.

Meet our leadership team

Pierre C Dromel, Ph.D.

Co-Founder & Chief Executive Officer

Deepti Singh, Ph.D.

Pierre C Dromel, Ph.D.

Co-Founder & Chief Scientific Officer

Patrick Jiang

Pierre C Dromel, Ph.D.

Patrick Jiang

Chief Business Officer

Scientific and Clinical Advisory Board

Myron Spector, Ph.D.

Motoichi Kurisawa, Ph.D.

Co-Founder & Director

Motoichi Kurisawa, Ph.D.

Scientific Advisor

Michael Young, Ph.D.

Motoichi Kurisawa, Ph.D.

Michael Young, Ph.D.

Co-Founder & Chairman of the Board

Dean Eliott, M.D.

Motoichi Kurisawa, Ph.D.

Michael Young, Ph.D.

Clinical Advisor

InGel Therapeutics

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept